/Investor DB

New York Angels — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Front Range BiosciencesinSep 2019 · $8.5M

US-focused tissue culture cloning and biotech.

Boulder, US

Christopher Zalewski(Founder)inJonathan Vaught(Founder)inNick Hofmeister(Founder)

Co-investorsKEY Investment PartnersAFI Capital PartnersArcadian CapitalHALLEY Venture PartnersMilitello CapitalPhyto Partners+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.